Optimizing Acyclic Identification of Aptamers

The minimal human alpha-thrombin binding aptamer, d(GGTTGGTGTGGTTGG), has previously been successfully identified from a DNA library of randomized hairpin loop, m=15, with the High Throughput Screening of Aptamers (HTSA) technique, later termed Acyclic Identification of Aptamers (AIA). AIA eliminated the need for multiple cycles of in vitro evolution typically used for aptamer discovery by employing libraries with an overrepresentation of all possible sequences and high throughput sequencing. Although the method was successful at identifying the thrombin binding aptamer, improvements to partitioning and sample preparation inconsistencies encountered during replication attempts were necessary in order to maximize its value. Subsequent revisions and variations of the protocol improved and streamlined the work-flow such that the thrombin binding aptamer (TBA) and multiple variants were identified as high affinity sequences using the ligation based m=15 DNA hairpin loop library mentioned above. The revised AIA protocol was also successful for identifying TBA and multiple variants in a nuclease resistant, modified 2’-OMe RNA/DNA chimera library. Sample throughput was increased with the introduction of indexed adapters containing sequence “barcodes” that facilitate multiplexing during high throughput sequencing. To eliminate the constraints of the hairpin loop library structure, a library based on direct amplification, the “adapter” library was designed. The m=15 DNA and m=15 2’-OMe RNA/DNA chimera adapter libraries were unsuccessful at identifying TBA from the library pool, likely due to interference from the flanking adapter regions required for PCR amplification. A secondary PCR product identified during sample work-up was also characterized. This prompted a significant interest in creating the ability to accurately assess whether or not a sample should be sequenced prior to consuming valuable resources. To accomplish this, the capture of a minimally flanked library (pACAC-m15-CACA) with full length adapters and no requirement for amplification was optimized. The library provides greater flexibility in secondary structure formation and was shown to successfully identify TBA from an over-represented library pool. Amplification-free AIA introduced the unique ability to predict relative maximum sequence frequencies based on the quantity of recovered library, initial degree of over-representation, and anticipated data output. The ability to predict whether or not a sequence could be counted above background was used to assess whether that sample would be sequenced, ultimately saving time and money. To expand the applicability of the tailed libraries and amplification free protocol, a novel partitioning method that eliminated the requirement for protein immobilization was developed. Reversible formaldehyde cross-linking in conjunction with Electrophoretic Mobility Shift Assay was used to successfully identify TBA above background in proof of concept experiments using amplification free sample preparation. The ability to perform AIA partitioning in solution provides greater flexibility in target selection, including mixtures of proteins. The method also effectively reduces the aptamer off-rate to zero by covalently linking high and moderate affinity sequences to the protein target during selection, an advantage over protein immobilization for partitioning where loss of some DNA from a reversibly bound complex is inevitable. The sample preparation techniques that evolved over the course of this work offer superior control and predictability in the outcome of high throughput sequencing data. This was aided by absolute quantification with qPCR CopyCount software that effectively improved library quantification, distribution of indices, and cluster quality, which is crucial for maximization of data output on Illumina sequencing platforms. Consistent, high quality data eliminates the potential for costly resequencing. Future experiments will capitalize on the breadth of improvements to the AIA method described in this work. OPTIMIZING ACYCLIC IDENTIFICATION OF APTAMERS By Caitlin M. Miller B.S. Seton Hall University, 2009 Dissertation Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry Syracuse University December 2015 Copyright © Caitlin M. Miller 2015 All Rights Reserved

[1]  Ettore Novellino,et al.  High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity , 2012, Nucleic acids research.

[2]  Sam F. Y. Li,et al.  Selection of aptamers for signal transduction proteins by capillary electrophoresis , 2010, Electrophoresis.

[3]  D. Guyer,et al.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.

[4]  V. Erdmann,et al.  Mirror-image RNA that binds D-adenosine , 1996, Nature Biotechnology.

[5]  A. Tulinsky,et al.  The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. , 1994, The Journal of biological chemistry.

[6]  T. Brown,et al.  Biocompatible artificial DNA linker that is read through by DNA polymerases and is functional in Escherichia coli , 2011, Proceedings of the National Academy of Sciences.

[7]  Michael Musheev,et al.  Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. , 2005, Journal of the American Chemical Society.

[8]  M Yarus,et al.  Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.

[9]  A. Van Schepdael,et al.  Selection and Characterization of DNA Aptamers for Egg White Lysozyme , 2010, Molecules.

[10]  Victor Okhonin,et al.  Selection of smart aptamers by methods of kinetic capillary electrophoresis. , 2006, Analytical chemistry.

[11]  Michael B. Mathews,et al.  A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.

[12]  Volker A. Erdmann,et al.  Mirror-design of L-oligonucleotide ligands binding to L-arginine , 1996, Nature Biotechnology.

[13]  M. Cosgrove,et al.  On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex*♦ , 2009, The Journal of Biological Chemistry.

[14]  R. Jenison,et al.  Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion. , 1998, Antisense & nucleic acid drug development.

[15]  L. C. Bock,et al.  In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. , 1993, Blood.

[16]  P. Giangrande,et al.  Therapeutic applications of DNA and RNA aptamers. , 2009, Oligonucleotides.

[17]  A. Ellington,et al.  Binding of herpes simplex virus-1 US11 to specific RNA sequences , 2005, Nucleic acids research.

[18]  D. Murray,et al.  DNA-protein crosslinks: their induction, repair, and biological consequences. , 2005, Mutation research.

[19]  A. Heeger,et al.  Micromagnetic selection of aptamers in microfluidic channels , 2009, Proceedings of the National Academy of Sciences.

[20]  Hua-Zhong Yu,et al.  Design and testing of aptamer-based electrochemical biosensors for proteins and small molecules. , 2009, Bioelectrochemistry.

[21]  Zoltán Konthur,et al.  Probing the SELEX Process with Next-Generation Sequencing , 2011, PloS one.

[22]  F. Eckstein,et al.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.

[23]  A D Ellington,et al.  Isozyme-specific inhibition of protein kinase C by RNA aptamers. , 1994, The Journal of biological chemistry.

[24]  Paul J. Hatala,et al.  DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER , 2007 .

[25]  S. Klußmann,et al.  Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo* , 2010, The Journal of Biological Chemistry.

[26]  J. Lis,et al.  New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization , 2014, Molecular therapy. Nucleic acids.

[27]  Anthony D. Keefe,et al.  Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. , 2005, Chemistry & biology.

[28]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[29]  S. Gopinath Methods developed for SELEX , 2006, Analytical and bioanalytical chemistry.

[30]  H. Gralnick,et al.  The carbohydrate of human thrombin: structural analysis of glycoprotein oligosaccharides by mass spectrometry. , 1983, Archives of biochemistry and biophysics.

[31]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[32]  Stephen A. Williams,et al.  Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer , 2010, PloS one.

[33]  J. Bruno Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics , 2015, Molecules.

[34]  B. Cosmi ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent. , 2009, Current opinion in molecular therapeutics.

[35]  R. Kuchta,et al.  Polymerization of 2'-fluoro- and 2'-O-methyl-dNTPs by human DNA polymerase alpha, polymerase gamma, and primase. , 2000, Biochemical pharmacology.

[36]  Michael Musheev,et al.  Non-SELEX selection of aptamers. , 2006, Journal of the American Chemical Society.

[37]  S. Klußmann,et al.  A DNA Spiegelmer to staphylococcal enterotoxin B. , 2003, Nucleic acids research.

[38]  Dong-Ki Lee,et al.  A sol-gel-based microfluidics system enhances the efficiency of RNA aptamer selection. , 2011, Oligonucleotides.

[39]  Weihong Tan,et al.  Nucleic acid aptamers for biosensors and bio-analytical applications. , 2009, The Analyst.

[40]  Mauricio G. Cohen,et al.  The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome. , 2012, Future cardiology.

[41]  C H Heldin,et al.  Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.

[42]  M. Willis,et al.  Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers. , 2000, Journal of biotechnology.

[43]  Liguang Xu,et al.  Building an aptamer/graphene oxide FRET biosensor for one-step detection of bisphenol A. , 2015, ACS applied materials & interfaces.

[44]  L. Gold,et al.  Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Steitz,et al.  Sno Storm in the Nucleolus: New Roles for Myriad Small RNPs , 1997, Cell.

[46]  J. Keene,et al.  Exploring molecular diversity with combinatorial shape libraries. , 1994, Trends in biochemical sciences.

[47]  S. Klußmann,et al.  An L-RNA-based aquaretic agent that inhibits vasopressin in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. M. Healy,et al.  First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers , 2007, Circulation.

[49]  David D. Smith,et al.  Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. , 2011, Methods.

[50]  Allen D. Delaney,et al.  Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing , 2007, Nature Methods.

[51]  M. Bowser,et al.  In vitro evolution of functional DNA using capillary electrophoresis. , 2004, Journal of the American Chemical Society.

[52]  C. Lorenz,et al.  Genomic systematic evolution of ligands by exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs independent of their expression levels , 2006, Nature Protocols.

[53]  A. Ellington,et al.  Adapting selected nucleic acid ligands (aptamers) to biosensors. , 1998, Analytical chemistry.

[54]  V. C. Ozalp,et al.  Aptamers: molecular tools for medical diagnosis. , 2015, Current topics in medicinal chemistry.

[55]  Carlotta Guiducci,et al.  More DNA-Aptamers for Small Drugs: A Capture-SELEX Coupled with Surface Plasmon Resonance and High-Throughput Sequencing. , 2015, ACS combinatorial science.

[56]  Catherine Lozupone,et al.  Selection of the simplest RNA that binds isoleucine. , 2003, RNA.

[57]  Penmetcha K. R. Kumar,et al.  Molecular beacon aptamer fluoresces in the presence of Tat protein of HIV‐1 , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[58]  Andrew D. Ellington,et al.  Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. , 1997, Chemical reviews.

[59]  E. Wang,et al.  Highly sensitive and specific colorimetric detection of cancer cells via dual-aptamer target binding strategy. , 2015, Biosensors & bioelectronics.

[60]  Anthony D. Keefe,et al.  Aptamers as candidate therapeutics for cardiovascular indications. , 2008, Current opinion in pharmacology.

[61]  J. Szostak,et al.  Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.

[62]  R. Knight,et al.  Analyzing partially randomized nucleic acid pools: straight dope on doping. , 2003, Nucleic acids research.

[63]  P. Schimmel,et al.  Protein synthesis editing by a DNA aptamer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  K. Thompson,et al.  2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics. , 2006, Oligonucleotides.

[65]  R. Y. Tsai,et al.  Identification of DNA Recognition Sequences and Protein Interaction Domains of the Multiple-Zn-Finger Protein Roaz , 1998, Molecular and Cellular Biology.

[66]  D. Wagner,et al.  Inhibition of von Willebrand factor‐mediated platelet activation and thrombosis by the anti‐von Willebrand factor A1‐domain aptamer ARC1779 , 2009, Journal of thrombosis and haemostasis : JTH.

[67]  R. Sousa,et al.  A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs. , 2002, Nucleic acids research.

[68]  D. M. Brown,et al.  An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. , 1996, Journal of molecular biology.

[69]  T. Yokoyama,et al.  Characterization and application of a novel RNA aptamer against the mouse prion protein. , 2006, Journal of biochemistry.

[70]  Matthew C. Cowperthwaite,et al.  Bioinformatic Analysis of the Contribution of Primer Sequences to Aptamer Structures , 2008, Journal of Molecular Evolution.

[71]  C. Ferreira,et al.  DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers , 2006, Tumor Biology.

[72]  Robert Langer,et al.  Nanotechnology and Aptamers: Applications in Drug Delivery , 2022 .

[73]  M Yarus,et al.  Three small ribooligonucleotides with specific arginine sites. , 1993, Biochemistry.

[74]  D. Shangguan,et al.  Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.

[75]  B. Cullen,et al.  Regulatory pathways governing HIV-1 replication , 1989, Cell.

[76]  Seung Soo Oh,et al.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.

[77]  Nadia Nikolaus,et al.  Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics , 2012, Journal of analytical methods in chemistry.

[78]  M. Bowser,et al.  Capillary electrophoresis-SELEX selection of catalytic DNA aptamers for a small-molecule porphyrin target. , 2013, Analytical chemistry.

[79]  J. Feigon,et al.  Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Jon Ashley,et al.  Selection of bovine catalase aptamers using non‐SELEX , 2012, Electrophoresis.

[81]  Gary A. Clawson,et al.  The Shorter the Better: Reducing Fixed Primer Regions of Oligonucleotide Libraries for Aptamer Selection , 2009, Molecules.

[82]  G. Clawson,et al.  Minimal primer and primer-free SELEX protocols for selection of aptamers from random DNA libraries. , 2008, BioTechniques.

[83]  A. Ellington,et al.  Aptamer beacons for the direct detection of proteins. , 2001, Analytical biochemistry.

[84]  K. Scherrer,et al.  A rapid and sensitive method for detection of proteins in polyacrylamide SDS gels: Staining with ethidium bromide , 1979, Molecular Biology Reports.

[85]  Jesse Dabney,et al.  Length and GC-biases during sequencing library amplification: a comparison of various polymerase-buffer systems with ancient and modern DNA sequencing libraries. , 2012, BioTechniques.

[86]  G. F. Joyce,et al.  Deep sequencing analysis of mutations resulting from the incorporation of dNTP analogs , 2010, Nucleic acids research.

[87]  R. Schultz,et al.  Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties. , 1996, Nucleic acids research.

[88]  Sheela M. Waugh,et al.  2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.

[89]  Seung Soo Oh,et al.  Generation of highly specific aptamers via micromagnetic selection. , 2009, Analytical chemistry.

[90]  Abhishek Parashar,et al.  Aptamers in Therapeutics. , 2016, Journal of clinical and diagnostic research : JCDR.

[91]  E. Ng,et al.  Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases , 2006, Annals of the New York Academy of Sciences.

[92]  L. Gold,et al.  Interactions of Escherichia coli RNA with bacteriophage MS2 coat protein: genomic SELEX. , 2000, Nucleic acids research.

[93]  Magda Tsolaki,et al.  Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. , 2013, Journal of Alzheimer's disease : JAD.

[94]  S. Niranjanakumari,et al.  Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. , 2002, Methods.

[95]  T. Yeates,et al.  Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). , 1996, Journal of molecular biology.

[96]  Kevin W Plaxco,et al.  Structure-switching biosensors: inspired by Nature. , 2010, Current opinion in structural biology.

[97]  George Quick,et al.  Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.

[98]  A. Ellington,et al.  Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA , 2004, Nature Biotechnology.

[99]  S. Swaminathan,et al.  A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. , 1993, Biochemistry.

[100]  L. J. Maher,et al.  Selection and characterization of an RNA decoy for transcription factor NF-kappa B. , 1999, Biochemistry.

[101]  Larry Gold,et al.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.

[102]  L. Gold,et al.  A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[103]  B. Jilma,et al.  A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease , 2010, Thrombosis and Haemostasis.

[104]  J C Cox,et al.  Automated selection of anti-protein aptamers. , 2001, Bioorganic & medicinal chemistry.

[105]  Michael Famulok,et al.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. , 2007, Chemical reviews.

[106]  Stephen A. Williams,et al.  Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool , 2012, PloS one.

[107]  Primer-free aptamer selection using a random DNA library. , 2010, Methods in molecular biology.

[108]  M. Bowser,et al.  In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. , 2004, Analytical chemistry.

[109]  Kemin Wang,et al.  Label-free and turn-on aptamer strategy for cancer cells detection based on a DNA-silver nanocluster fluorescence upon recognition-induced hybridization. , 2013, Analytical chemistry.

[110]  A. Tulinsky,et al.  An ambiguous structure of a DNA 15-mer thrombin complex. , 1996, Acta crystallographica. Section D, Biological crystallography.

[111]  A D Ellington,et al.  In Vitro Selection of RNA Molecules That Inhibit the Activity of Ricin A-chain* , 2000, The Journal of Biological Chemistry.

[112]  J. Eikelboom,et al.  Coagulation Factor IXa as a Target for Treatment and Prophylaxis of Venous Thromboembolism , 2010, Arteriosclerosis, Thrombosis and Vascular Biology.

[113]  Juewen Liu,et al.  Aptamer-based biosensors for biomedical diagnostics. , 2014, The Analyst.

[114]  Christopher B. Burge,et al.  Direct visualization of DNA affinity landscapes using a highthroughput sequencing instrument , 2011 .

[115]  M. Price,et al.  Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting. , 2005, Journal of immunological methods.

[116]  S. Jayasena Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[117]  A. Schwienhorst Direct thrombin inhibitors – a survey of recent developments , 2006, Cellular and Molecular Life Sciences CMLS.

[118]  Jack W. Szostak,et al.  An RNA motif that binds ATP , 1993, Nature.

[119]  M. Sandros,et al.  Zeptomole Detection of C-Reactive Protein in Serum by a Nanoparticle Amplified Surface Plasmon Resonance Imaging Aptasensor , 2014, Scientific Reports.

[120]  R. Knight,et al.  Size, constant sequences, and optimal selection. , 2005, RNA.

[121]  L. Gold,et al.  Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. , 1995, Virology.

[122]  Peter J. Woolf,et al.  A Mechanistic Model of PCR for Accurate Quantification of Quantitative PCR Data , 2010, PloS one.

[123]  M. Zourob,et al.  Aptamer-based label-free impedimetric biosensor for detection of progesterone. , 2015, Analytical chemistry.

[124]  Mark P. McPike,et al.  Acyclic Identification of Aptamers for Human alpha-Thrombin Using Over-Represented Libraries and Deep Sequencing , 2011, PloS one.

[125]  F. Luo,et al.  Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. , 2007, Biochemical and biophysical research communications.

[126]  J. Hope,et al.  Characterization of 2′-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion* , 2003, Journal of Biological Chemistry.

[127]  K. Adelman,et al.  In vitro selection of packaging sites in a double-stranded RNA virus , 1997, Journal of virology.

[128]  J C Cox,et al.  Automated RNA Selection , 1998, Biotechnology progress.

[129]  M. Bowser,et al.  In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. , 2005, Journal of the American Chemical Society.

[130]  Andrew D. Ellington,et al.  Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. , 2010, Cancer research.

[131]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.

[132]  Yingfu Li,et al.  Recognition of anionic porphyrins by DNA aptamers. , 1996, Biochemistry.

[133]  M. Fischer,et al.  Just in time-selection: A rapid semiautomated SELEX of DNA aptamers using magnetic separation and BEAMing. , 2014, Analytical chemistry.

[134]  B. Sullenger,et al.  A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function , 2008, Angiogenesis.

[135]  J. Shendure,et al.  A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes. , 2014, Journal of molecular biology.

[136]  I Karube,et al.  In vitro selection of DNA aptamers which bind to cholic acid. , 2000, Biochimica et biophysica acta.

[137]  A. Aitken,et al.  The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M* , 2000, The Journal of Biological Chemistry.

[138]  M. Buckle,et al.  DNA-protein interactions : a practical approach , 2000 .

[139]  Zhaofeng Luo,et al.  In vitro selection of high-affinity DNA aptamers for streptavidin. , 2009, Acta biochimica et biophysica Sinica.

[140]  Edouard E Galyov,et al.  Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[141]  George Georgiou,et al.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. , 2002, Nucleic acids research.

[142]  S. Klußmann,et al.  Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist , 2005, Nucleic acids research.

[143]  John T McDevitt,et al.  Aptamer-based sensor arrays for the detection and quantitation of proteins. , 2004, Analytical chemistry.

[144]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[145]  Anca M. Segall,et al.  In Vitro Selection of Integration Host Factor Binding Sites , 1999, Journal of bacteriology.

[146]  M. Bowser,et al.  Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. , 2005, Analytical chemistry.

[147]  Letha J. Sooter,et al.  Automated acquisition of aptamer sequences. , 2002, Combinatorial chemistry & high throughput screening.

[148]  In vitro selection of RNA aptamers. , 2000, Methods in enzymology.

[149]  Y. Zu,et al.  Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.

[150]  J. Swenberg,et al.  Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers. , 2010, Journal of the American Chemical Society.

[151]  K K Kidd,et al.  Modeling of heteroduplex formation during PCR from mixtures of DNA templates. , 1992, PCR methods and applications.

[152]  B. Gatto,et al.  In vitro selection of DNA aptamers that bind L-tyrosinamide. , 2001, Bioorganic & medicinal chemistry.

[153]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[154]  Y. Iwakura,et al.  RNA packaging signal of human immunodeficiency virus type 1. , 1992, Virology.

[155]  S. Klußmann,et al.  Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX. , 2003, Nucleic acids research.

[156]  K. Machida,et al.  Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. , 1997, Virology.

[157]  T. Hianik,et al.  Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. , 2007, Bioelectrochemistry.

[158]  Han Wei Hou,et al.  Identification of malaria parasite-infected red blood cell surface aptamers by inertial microfluidic SELEX (I-SELEX) , 2015, Scientific Reports.

[159]  Christopher M Rose,et al.  Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment. , 2010, The Analyst.

[160]  E. Gilboa,et al.  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.

[161]  L. Kèlland,et al.  Discovery and development of anticancer aptamers , 2006, Molecular Cancer Therapeutics.

[162]  S. Klußmann,et al.  Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics. , 2015, Drug discovery today.

[163]  R. Sousa,et al.  Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP). , 1999, Nucleic acids research.

[164]  B. Eaton,et al.  The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets. , 1997, Current opinion in chemical biology.

[165]  M. Cosgrove,et al.  Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation* , 2015, The Journal of Biological Chemistry.